People · Operator
Named in public records as an officer, director or promoter · active 2013–2025 · Pharmaceuticals, Healthtech, Biotechnology, Agriculture
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| BlossomHill Therapeutics, Inc. | — | Pharmaceuticals | Series C | $245.8M | $452.2M | 2023 |
| TP Therapeutics, Inc. | — | Pharmaceuticals | Series C | $126.4M | $2.8B | 2017 |
| Cardiva Medical, Inc. | — | Healthtech | Series C | $104.7M | $1.2B | 2017 |
| Apexigen, Inc. | — | Biotechnology | Series C | $66.4M | $85.5M | 2013 |
| RevMAb Biosciences, Inc. | — | Biotechnology | Seed | $6.6M | $104.0M | 2017 |
| PastureMap Inc. | — | Agriculture | Seed | $1.5M | $16.4M | 2017 |
George Lee at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside George Lee on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| BIHUA CHEN | 2 | 14 |
| Yishan Li | 2 | 4 |
| Kenneth Fong | 2 | 3 |
| Carl Gordon | 1 | 24 |
| Scott Smith | 1 | 16 |
| Robert White | 1 | 8 |
| Gordon Ringold | 1 | 7 |
| John Russell | 1 | 5 |
| Rick Anderson | 1 | 4 |
| KAREN LIU | 1 | 4 |
| Hongbo Lu | 1 | 4 |
| Lewis J. Shuster | 1 | 4 |
| Matthew Crawford | 1 | 3 |
| George J. Lee | 1 | 3 |
| William Rutter | 1 | 3 |
| Dan Zabrowski | 1 | 2 |
| Michael T. Daniel | 1 | 2 |
| JINGRONG JEAN CUI | 1 | 2 |
| Jeryl Hilleman | 1 | 2 |
| Charles T. Maroney | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.